(Q30352511)

20 June 2017

HIV-1 subtype C in vitro growth and coreceptor utilization. (English)

1 reference

20 June 2017

13

Max Essex

1 reference

20 June 2017

Sikhulile M Moyo

10

0 references

Thumbi Ndung'u

object named as

Thumbi Ndung'u

1

0 references

Simani Gaseitsiwe

6

object named as

Simani Gaseitsiwe

1 reference

20 June 2017

5

Keabetswe Bedi

1 reference

20 June 2017

Florence Doualla-Bell

7

object named as

Florence Doualla-Bell

1 reference

20 June 2017

9

Ibou Thior

1 reference

20 June 2017

4

Fatima Chand

1 reference

20 June 2017

3

Mary Fran McLane

1 reference

20 June 2017

Enoch Sepako

2

1 reference

20 June 2017

Trevor Peter

8

1 reference

20 June 2017

Peter B Gilbert

11

1 reference

20 June 2017

Vladimir A Novitsky

12

1 reference

20 June 2017

language of work or name

English

0 references

publication date

10 January 2006

1 reference

20 June 2017

1 reference

20 June 2017

347

1 reference

20 June 2017

2

1 reference

20 June 2017

247-260

1 reference

Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C.

20 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

HIV-1 LTR subtype and perinatal transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Biological, serological, and genetic characterization of HIV-1 subtype E isolates from northern Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Construction and analysis of an infectious human Immunodeficiency virus type 1 subtype C molecular clone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

HIV type 1 A/J recombinant with a pronounced pol gene mosaicism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Estimated Global Distribution and Regional Spread of HIV-1 Genetic Subtypes in the Year 2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Complete nucleotide sequences of functional clones of the AIDS virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Epidemic expansion of HIV type 1 subtype C and recombinant genotypes in Tanzania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Standard Conditions of Virus Isolation Reveal Biological Variability of HIV Type 1 in Different Regions of the World

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Differences in chemokine coreceptor usage between genetic subtypes of HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Characterization of full-length HIV type 1 subtype C sequences from South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Change in co-receptor usage of current South African HIV-1 subtype C primary isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Characterization and selection of HIV-1 subtype C isolates for use in vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Statistical measures of DNA sequence dissimilarity under Markov chain models of base composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Genetic diversity and high proportion of intersubtype recombinants among HIV type 1-infected pregnant women in Kisumu, western Kenya.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Inter- and intra-genic intersubtype HIV-1 recombination in rural and semi-urban Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

7 January 2021

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

7 January 2021

Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

7 January 2021

The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

7 January 2021

Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

7 January 2021

Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

7 January 2021

Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

7 January 2021

Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

7 January 2021

The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.047

7 January 2021

10.1016/J.VIROL.2005.11.047

Identifiers

DOI

1 reference

20 June 2017

1 reference